The effect of ivermectin on the viral load and culture viability in early treatment of nonhospitalized patients with mild COVID-19 – a double-blind, randomized placebo-controlled trial

OBJECTIVES: Ivermectin, an antiparasitic agent, also has antiviral properties. In this study, we aimed to assess whether ivermectin has anti-SARS-CoV-2 activity. METHODS: In this double-blinded trial, we compared patients receiving ivermectin for 3 days versus placebo in nonhospitalized adult patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Biber, Asaf, Harmelin, Geva, Lev, Dana, Ram, Li, Shaham, Amit, Nemet, Ital, Kliker, Limor, Erster, Oran, Mandelboim, Michal, Schwartz, Eli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262706/
https://www.ncbi.nlm.nih.gov/pubmed/35811080
http://dx.doi.org/10.1016/j.ijid.2022.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262706/
https://www.ncbi.nlm.nih.gov/pubmed/35811080
http://dx.doi.org/10.1016/j.ijid.2022.07.003

Ejemplares similares